Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer

Anticancer Research

Volumn 22, Issue 6 A, 2002, Pages 3337-3342

  Yang, Jia Lin ^a,b   Jackson, Paul ^a,b   Yu, Yan ^a,b   Russell, Pamela J ^a,b   Markovic, Boban ^b   Crowe, Philip J ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Colorectal cancer; KAI1; Metastasis; Survival

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GENE KAI1; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER METASTASIS; PRIORITY JOURNAL; PROTEIN CONTENT; TUMOR SUPPRESSOR GENE;

ANALYSIS OF VARIANCE; ANTIGENS, CD; COLORECTAL NEOPLASMS; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KANGAI-1 PROTEIN; LIVER NEOPLASMS; MEMBRANE GLYCOPROTEINS; PARAFFIN EMBEDDING; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SURVIVAL RATE;

EID: 0036871139     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dong JT, Lamb PW, Rinker-Schaeffer CW et al: KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268: 884-886, 1995.
2. Adachi M, Taki T, Ieki Y et al: Correlation of KAI1 /CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 56: 1751-1755, 1996.
3. Guo X, Friess YZ, Di Mola FF et al: KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Hepatol 28: 1481-1488, 1998.
4. Ueda T, Ichikawa T, Tamaru J et al: Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer. Amer J Pathol 149: 1435-1440, 1996.
5. Ow K, Delprado W, Fisher R et al: Relationship between expression of KAII metastasis suppressor and other markers of advanced bladder cancer. J Pathol 191: 39-45, 2000.
6. Yang XH, Wei L, Tang C et al: KAI1 protein is down-regulated during the progression of human breast cancer. Clin Cancer Res 6: 3424-3429, 2000.
7. Huang CI, Kohno, N, Ogawa E et al: Correlation of reduction in MRP/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Amer J Pathol 153: 973-983, 1998.
8. Takaoka A, Hinoda Y, Satoh S et al: Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene 16: 1443-1453, 1998.
9. Yang JL, Jackson P, Yu Y et al: Invasion and metastasis correlate with a loss of KAI1 expression in cell lines derived from human sporadic colon cancer. GI Cancer 3: 313-322, 2001.
10. Lombardi DP, Geradts J, Foley JF et al: Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res 59: 5724-5731, 1999.
11. Maurer CA, Graber HU, Friess H et al: Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and metastasis. Surgery 126: 869-880, 1999.
12. Mikami T, Ookawa K, Shimoyama T et al: KAI1, CAR, and Smad4 expression in the progression of colorectal tumor. J Gastroenterol 36: 465-469, 2001.
13. Yang JL, Ow KT, Ham JM et al: Higher expression of oncoprotein c-myc, c-neu, PCNA and p53 in metastasising colorectal cancer (CRC) than in non-metastasising CRC. Ann Surg Oncol 3: 574-579, 1996.
14. Yang JL, Yu Y, Markovic B et al: Over-expression of c-erbB2 mRNA and/or c-neu oncoprotein is a predictor for metastases from colorectal cancer. Anticancer Res 17: 1023-1026, 1997.
15. Markovic B, Wu ZH, Chesterman CN et al: Quantitation of Fc y RII mRNA in platelets and mega-caryoblastic cell lines by a new method of in situ hybridization. J Immunol Methods 172: 105-114, 1994.
16. Yu Y, Yang JL, Marcovic B et al: Loss of KAI1 messenger RNA expression in both high grade and invasive bladder cancers. Clin Cancer Res 3: 1045-1049, 1997.
17. Eeba HP, Gunning P and Kedes L: Nucleotide sequence of the human γ cytoskeletal actin mRNA: anomalous evolution of vertebrate non-muscle actin genes. Nucl Acids Res 14: 5275-5295, 1986.
18. Muneyaki T, Watanabe M, Yamanaka M et al: KAI1/CD82 expression as a prognostic factor in sporadic colorectal cancer. Anti Cancer Res 21: 3581-3587, 2001.
19. Guo XZ, Friess H, Maurer C et al: KAI1 is unchanged in metastatic and non-metastatic esophogeal and gastric cancer. Cancer Res 58: 753-758, 1998.
20. Bouras T and Frauman AG: Expression of the prostate cancer metastasis suppressor KAI1 in primary prostate cancers: a biphasic relationship with tumour grade. J Pathol 188: 382-288, 1999.
21. Guo XZ, Friess H, Graber HU et al: KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res 56: 4876-4880, 1996.
22. White A, Lamb PW and Barrett JC: Frequent downregulation of the KAII (CD82) metastasis suppressor protein in human cancer cell lines. Oncogene 16: 3143-3149, 1998.
23. Phillips KK, White AE, Hicks DJ et al: Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Molec Carcinogen 21: 111-120, 1998.